Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with MYL as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.5%||iShares U.S. Pharmaceutical ETF (IHE)||+25.17 (16.56%)|
|3.43%||iShares Nasdaq Biotechnology Index Fund (IBB)||+58.55 (19.11%)|
|3.01%||SPDR S&P Pharmaceuticals ETF (XPH)||+16.29 (15.10%)|
|1.25%||Vanguard Mid-Cap Value ETF - DNQ (VOE)||+3.72 (4.16%)|
|0%||ProShares Ultra Nasdaq Biotechnology (BIB)||+24.74 (38.71%)|
Company Description (as filed with the SEC)
Unless otherwise indicated, the following discussion relates to Mylan Inc. prior to the consummation of the Transaction, defined below, on February 27, 2015. Mylan Inc., along with its subsidiaries (collectively, the "Company," "Mylan," "our" or "we"), is a leading global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan is committed to setting new standards in health care and our mission is to provide the world's 7 billion people access to high quality medicine. To do so, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. Mylan offers one of the industry's broadest product portfolios, including approximately 1,400 marketed products, to customers in approximately 140 countries and territories. ... More ...
Where does MYL fit in the risk graph?
|Annual EPS Est:||$3.56|
|Quarterly EPS Est:||0.92|